Research on Development Paths of Pharmaceutical E-Commerce Industry Based on SWOT Analysis

本文运用SWOT分析框架，系统梳理医药电商行业的内部优势与劣势以及外部环境的机会与威胁，结合政策演进、市场需求及技术变革，提出行业发展的战略路径，为企业竞争与政策制定提供参考。研究发现，医药电商虽具备商业模式创新、方便快捷、存在资源壁垒等优势，但面临专业服务能力不足、合规与信任挑战的劣势。在政策红利释放、消费习惯变迁带来的机遇下，也需应对政策与监管风险、市场竞争白热化威胁。基于此，建议行业通过强化技术驱动、深化医保对接、共建处方流转平台、培育用户心智、差异化竞争、生态化布局、合规体系建设及区域深耕战略实现可持续发展。This paper systematically combs the internal strengths and weaknesses of the pharmaceutical e-commerce industry, as well as the opportunities and threats in the external environment, using the SWOT analysis framework. By integrating policy evolution, market demands, and technological changes, it proposes strategic paths for industry development to provide references for enterprise competition and policy formulation. The study finds that although pharmaceutical e-commerce has advantages such as innovative business models, convenience, and resource barriers, it faces disadvantages such as insufficient professional service capabilities, compliance challenges, and trust issues. Amid the opportunities brought by policy dividends and changing consumer habits, it also needs to address threats such as policy and regulatory risks and fierce market competition. Based on this, the paper suggests that the industry should achieve sustainable development through strategies such as strengthening technology-driven development, deepening medical insurance integration, jointly building prescription circulation platforms, cultivating user awareness, pursuing differentiated competition, ecological layout, compliance system construction, and regional deepening.